img

Global PSMA Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PSMA Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

PSMA Antibody, also known as Prostate-Specific Membrane Antigen antibody, is a specific antibody used to detect and study PSMA protein (Prostate-Specific Membrane Antigen).
PSMA Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PSMA Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
PSMA is a membrane surface antigen that is highly expressed mainly in prostate tissue and is therefore often used as a marker for prostate cancer. In addition to its expression in prostate tissue, PSMA is also expressed at low levels in other tissues and tumors. Due to its important role in the diagnosis, staging and treatment of prostate cancer, PSMA antibodies have important application value in cancer diagnosis and research. PSMA antibody can be used to study the expression distribution of PSMA, diagnose prostate cancer, explore anti-tumor treatment strategies, etc., and help to understand the function and clinical application potential of PSMA in tumor biology.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PSMA Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sino Biological, Inc.
ACROBiosystems
Bio-Techne
Abcam
Elabscience Biotechnology Inc.
LifeSpan BioSciences, Inc
ProSci Incorporated
Boster Biological Technology
Abbexa
Assay Genie
Innovative Research
G&P Biosciences
Arigo Biolaboratories Corp.
Segment by Type
Monoclonal Antibody
Polyclonal Antibody

Segment by Application


Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PSMA Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PSMA Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PSMA Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of PSMA Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PSMA Antibody introduction, etc. PSMA Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of PSMA Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 PSMA Antibody Market Overview
1.1 PSMA Antibody Product Overview
1.2 PSMA Antibody Market Segment by Type
1.2.1 Monoclonal Antibody
1.2.2 Polyclonal Antibody
1.3 Global PSMA Antibody Market Size by Type
1.3.1 Global PSMA Antibody Market Size Overview by Type (2018-2029)
1.3.2 Global PSMA Antibody Historic Market Size Review by Type (2018-2024)
1.3.3 Global PSMA Antibody Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PSMA Antibody Sales Breakdown by Type (2018-2024)
1.4.2 Europe PSMA Antibody Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific PSMA Antibody Sales Breakdown by Type (2018-2024)
1.4.4 Latin America PSMA Antibody Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa PSMA Antibody Sales Breakdown by Type (2018-2024)
2 Global PSMA Antibody Market Competition by Company
2.1 Global Top Players by PSMA Antibody Sales (2018-2024)
2.2 Global Top Players by PSMA Antibody Revenue (2018-2024)
2.3 Global Top Players by PSMA Antibody Price (2018-2024)
2.4 Global Top Manufacturers PSMA Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 PSMA Antibody Market Competitive Situation and Trends
2.5.1 PSMA Antibody Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PSMA Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PSMA Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into PSMA Antibody Market
2.8 Key Manufacturers PSMA Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PSMA Antibody Status and Outlook by Region
3.1 Global PSMA Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global PSMA Antibody Historic Market Size by Region
3.2.1 Global PSMA Antibody Sales in Volume by Region (2018-2024)
3.2.2 Global PSMA Antibody Sales in Value by Region (2018-2024)
3.2.3 Global PSMA Antibody Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global PSMA Antibody Forecasted Market Size by Region
3.3.1 Global PSMA Antibody Sales in Volume by Region (2024-2029)
3.3.2 Global PSMA Antibody Sales in Value by Region (2024-2029)
3.3.3 Global PSMA Antibody Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global PSMA Antibody by Application
4.1 PSMA Antibody Market Segment by Application
4.1.1 Flow Cytometry
4.1.2 ELISA
4.1.3 Western Blot
4.1.4 Immunoprecipitation
4.1.5 Immunofluorescence
4.1.6 Others
4.2 Global PSMA Antibody Market Size by Application
4.2.1 Global PSMA Antibody Market Size Overview by Application (2018-2029)
4.2.2 Global PSMA Antibody Historic Market Size Review by Application (2018-2024)
4.2.3 Global PSMA Antibody Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PSMA Antibody Sales Breakdown by Application (2018-2024)
4.3.2 Europe PSMA Antibody Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific PSMA Antibody Sales Breakdown by Application (2018-2024)
4.3.4 Latin America PSMA Antibody Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa PSMA Antibody Sales Breakdown by Application (2018-2024)
5 North America PSMA Antibody by Country
5.1 North America PSMA Antibody Historic Market Size by Country
5.1.1 North America PSMA Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America PSMA Antibody Sales in Volume by Country (2018-2024)
5.1.3 North America PSMA Antibody Sales in Value by Country (2018-2024)
5.2 North America PSMA Antibody Forecasted Market Size by Country
5.2.1 North America PSMA Antibody Sales in Volume by Country (2024-2029)
5.2.2 North America PSMA Antibody Sales in Value by Country (2024-2029)
6 Europe PSMA Antibody by Country
6.1 Europe PSMA Antibody Historic Market Size by Country
6.1.1 Europe PSMA Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe PSMA Antibody Sales in Volume by Country (2018-2024)
6.1.3 Europe PSMA Antibody Sales in Value by Country (2018-2024)
6.2 Europe PSMA Antibody Forecasted Market Size by Country
6.2.1 Europe PSMA Antibody Sales in Volume by Country (2024-2029)
6.2.2 Europe PSMA Antibody Sales in Value by Country (2024-2029)
7 Asia-Pacific PSMA Antibody by Region
7.1 Asia-Pacific PSMA Antibody Historic Market Size by Region
7.1.1 Asia-Pacific PSMA Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific PSMA Antibody Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific PSMA Antibody Sales in Value by Region (2018-2024)
7.2 Asia-Pacific PSMA Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific PSMA Antibody Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific PSMA Antibody Sales in Value by Region (2024-2029)
8 Latin America PSMA Antibody by Country
8.1 Latin America PSMA Antibody Historic Market Size by Country
8.1.1 Latin America PSMA Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America PSMA Antibody Sales in Volume by Country (2018-2024)
8.1.3 Latin America PSMA Antibody Sales in Value by Country (2018-2024)
8.2 Latin America PSMA Antibody Forecasted Market Size by Country
8.2.1 Latin America PSMA Antibody Sales in Volume by Country (2024-2029)
8.2.2 Latin America PSMA Antibody Sales in Value by Country (2024-2029)
9 Middle East and Africa PSMA Antibody by Country
9.1 Middle East and Africa PSMA Antibody Historic Market Size by Country
9.1.1 Middle East and Africa PSMA Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa PSMA Antibody Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa PSMA Antibody Sales in Value by Country (2018-2024)
9.2 Middle East and Africa PSMA Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa PSMA Antibody Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa PSMA Antibody Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sino Biological, Inc.
10.1.1 Sino Biological, Inc. Company Information
10.1.2 Sino Biological, Inc. Introduction and Business Overview
10.1.3 Sino Biological, Inc. PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sino Biological, Inc. PSMA Antibody Products Offered
10.1.5 Sino Biological, Inc. Recent Development
10.2 ACROBiosystems
10.2.1 ACROBiosystems Company Information
10.2.2 ACROBiosystems Introduction and Business Overview
10.2.3 ACROBiosystems PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.2.4 ACROBiosystems PSMA Antibody Products Offered
10.2.5 ACROBiosystems Recent Development
10.3 Bio-Techne
10.3.1 Bio-Techne Company Information
10.3.2 Bio-Techne Introduction and Business Overview
10.3.3 Bio-Techne PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bio-Techne PSMA Antibody Products Offered
10.3.5 Bio-Techne Recent Development
10.4 Abcam
10.4.1 Abcam Company Information
10.4.2 Abcam Introduction and Business Overview
10.4.3 Abcam PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Abcam PSMA Antibody Products Offered
10.4.5 Abcam Recent Development
10.5 Elabscience Biotechnology Inc.
10.5.1 Elabscience Biotechnology Inc. Company Information
10.5.2 Elabscience Biotechnology Inc. Introduction and Business Overview
10.5.3 Elabscience Biotechnology Inc. PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Elabscience Biotechnology Inc. PSMA Antibody Products Offered
10.5.5 Elabscience Biotechnology Inc. Recent Development
10.6 LifeSpan BioSciences, Inc
10.6.1 LifeSpan BioSciences, Inc Company Information
10.6.2 LifeSpan BioSciences, Inc Introduction and Business Overview
10.6.3 LifeSpan BioSciences, Inc PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.6.4 LifeSpan BioSciences, Inc PSMA Antibody Products Offered
10.6.5 LifeSpan BioSciences, Inc Recent Development
10.7 ProSci Incorporated
10.7.1 ProSci Incorporated Company Information
10.7.2 ProSci Incorporated Introduction and Business Overview
10.7.3 ProSci Incorporated PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.7.4 ProSci Incorporated PSMA Antibody Products Offered
10.7.5 ProSci Incorporated Recent Development
10.8 Boster Biological Technology
10.8.1 Boster Biological Technology Company Information
10.8.2 Boster Biological Technology Introduction and Business Overview
10.8.3 Boster Biological Technology PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Boster Biological Technology PSMA Antibody Products Offered
10.8.5 Boster Biological Technology Recent Development
10.9 Abbexa
10.9.1 Abbexa Company Information
10.9.2 Abbexa Introduction and Business Overview
10.9.3 Abbexa PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Abbexa PSMA Antibody Products Offered
10.9.5 Abbexa Recent Development
10.10 Assay Genie
10.10.1 Assay Genie Company Information
10.10.2 Assay Genie Introduction and Business Overview
10.10.3 Assay Genie PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Assay Genie PSMA Antibody Products Offered
10.10.5 Assay Genie Recent Development
10.11 Innovative Research
10.11.1 Innovative Research Company Information
10.11.2 Innovative Research Introduction and Business Overview
10.11.3 Innovative Research PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Innovative Research PSMA Antibody Products Offered
10.11.5 Innovative Research Recent Development
10.12 G&P Biosciences
10.12.1 G&P Biosciences Company Information
10.12.2 G&P Biosciences Introduction and Business Overview
10.12.3 G&P Biosciences PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.12.4 G&P Biosciences PSMA Antibody Products Offered
10.12.5 G&P Biosciences Recent Development
10.13 Arigo Biolaboratories Corp.
10.13.1 Arigo Biolaboratories Corp. Company Information
10.13.2 Arigo Biolaboratories Corp. Introduction and Business Overview
10.13.3 Arigo Biolaboratories Corp. PSMA Antibody Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Arigo Biolaboratories Corp. PSMA Antibody Products Offered
10.13.5 Arigo Biolaboratories Corp. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PSMA Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PSMA Antibody Industrial Chain Analysis
11.4 PSMA Antibody Market Dynamics
11.4.1 PSMA Antibody Industry Trends
11.4.2 PSMA Antibody Market Drivers
11.4.3 PSMA Antibody Market Challenges
11.4.4 PSMA Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PSMA Antibody Distributors
12.3 PSMA Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal Antibody
Table 2. Major Company of Polyclonal Antibody
Table 3. Global PSMA Antibody Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global PSMA Antibody Sales by Type (2018-2024) & (K Units)
Table 5. Global PSMA Antibody Sales Market Share in Volume by Type (2018-2024)
Table 6. Global PSMA Antibody Sales by Type (2018-2024) & (US& Million)
Table 7. Global PSMA Antibody Market Share in Value by Type (2018-2024)
Table 8. Global PSMA Antibody Price by Type (2018-2024) & (US$/Unit)
Table 9. Global PSMA Antibody Sales by Type (2024-2029) & (K Units)
Table 10. Global PSMA Antibody Sales Market Share in Volume by Type (2024-2029)
Table 11. Global PSMA Antibody Sales by Type (2024-2029) & (US$ Million)
Table 12. Global PSMA Antibody Sales Market Share in Value by Type (2024-2029)
Table 13. Global PSMA Antibody Price by Type (2024-2029) & (US$/Unit)
Table 14. North America PSMA Antibody Sales by Type (2018-2024) & (K Units)
Table 15. North America PSMA Antibody Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe PSMA Antibody Sales (K Units) by Type (2018-2024)
Table 17. Europe PSMA Antibody Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific PSMA Antibody Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific PSMA Antibody Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America PSMA Antibody Sales (K Units) by Type (2018-2024)
Table 21. Latin America PSMA Antibody Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa PSMA Antibody Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa PSMA Antibody Sales by Type (2018-2024) & (US$ Million)
Table 24. Global PSMA Antibody Sales by Company (2018-2024) & (K Units)
Table 25. Global PSMA Antibody Sales Share by Company (2018-2024)
Table 26. Global PSMA Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global PSMA Antibody Revenue Share by Company (2018-2024)
Table 28. Global Market PSMA Antibody Price by Company (2018-2024) & (US$/Unit)
Table 29. Global PSMA Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global PSMA Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PSMA Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into PSMA Antibody Market
Table 33. Key Manufacturers PSMA Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global PSMA Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global PSMA Antibody Sales by Region (2018-2024) & (K Units)
Table 37. Global PSMA Antibody Sales Market Share in Volume by Region (2018-2024)
Table 38. Global PSMA Antibody Sales by Region (2018-2024) & (US$ Million)
Table 39. Global PSMA Antibody Sales Market Share in Value by Region (2018-2024)
Table 40. Global PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global PSMA Antibody Sales by Region (2024-2029) & (K Units)
Table 42. Global PSMA Antibody Sales Market Share in Volume by Region (2024-2029)
Table 43. Global PSMA Antibody Sales by Region (2024-2029) & (US$ Million)
Table 44. Global PSMA Antibody Sales Market Share in Value by Region (2024-2029)
Table 45. Global PSMA Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global PSMA Antibody Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global PSMA Antibody Sales by Application (2018-2024) & (K Units)
Table 48. Global PSMA Antibody Sales Market Share in Volume by Application (2018-2024)
Table 49. Global PSMA Antibody Sales by Application (2018-2024) & (US$ Million)
Table 50. Global PSMA Antibody Sales Market Share in Value by Application (2018-2024)
Table 51. Global PSMA Antibody Price by Application (2018-2024) & (US$/Unit)
Table 52. Global PSMA Antibody Sales by Application (2024-2029) & (K Units)
Table 53. Global PSMA Antibody Sales Market Share in Volume by Application (2024-2029)
Table 54. Global PSMA Antibody Sales by Application (2024-2029) & (US$ Million)
Table 55. Global PSMA Antibody Sales Market Share in Value by Application (2024-2029)
Table 56. Global PSMA Antibody Price by Application (2024-2029) & (US$/Unit)
Table 57. North America PSMA Antibody Sales by Application (2018-2024) (K Units)
Table 58. North America PSMA Antibody Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe PSMA Antibody Sales by Application (2018-2024) (K Units)
Table 60. Europe PSMA Antibody Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific PSMA Antibody Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific PSMA Antibody Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America PSMA Antibody Sales by Application (2018-2024) (K Units)
Table 64. Latin America PSMA Antibody Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa PSMA Antibody Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa PSMA Antibody Sales by Application (2018-2024) & (US$ Million)
Table 67. North America PSMA Antibody Sales by Country (2018-2024) & (K Units)
Table 68. North America PSMA Antibody Sales Market Share in Volume by Country (2018-2024)
Table 69. North America PSMA Antibody Sales by Country (2018-2024) & (US$ Million)
Table 70. North America PSMA Antibody Sales Market Share in Value by Country (2018-2024)
Table 71. North America PSMA Antibody Sales by Country (2024-2029) & (K Units)
Table 72. North America PSMA Antibody Sales Market Share in Volume by Country (2024-2029)
Table 73. North America PSMA Antibody Sales by Country (2024-2029) & (US$ Million)
Table 74. North America PSMA Antibody Sales Market Share in Value by Country (2024-2029)
Table 75. Europe PSMA Antibody Sales by Country (2018-2024) & (K Units)
Table 76. Europe PSMA Antibody Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe PSMA Antibody Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe PSMA Antibody Sales Market Share in Value by Country (2018-2024)
Table 79. Europe PSMA Antibody Sales by Country (2024-2029) & (K Units)
Table 80. Europe PSMA Antibody Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe PSMA Antibody Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe PSMA Antibody Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific PSMA Antibody Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific PSMA Antibody Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific PSMA Antibody Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific PSMA Antibody Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific PSMA Antibody Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific PSMA Antibody Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific PSMA Antibody Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific PSMA Antibody Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America PSMA Antibody Sales by Country (2018-2024) & (K Units)
Table 92. Latin America PSMA Antibody Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America PSMA Antibody Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America PSMA Antibody Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America PSMA Antibody Sales by Country (2024-2029) & (K Units)
Table 96. Latin America PSMA Antibody Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America PSMA Antibody Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America PSMA Antibody Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa PSMA Antibody Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa PSMA Antibody Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa PSMA Antibody Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa PSMA Antibody Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa PSMA Antibody Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa PSMA Antibody Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa PSMA Antibody Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa PSMA Antibody Sales Market Share in Value by Country (2024-2029)
Table 107. Sino Biological, Inc. Company Information
Table 108. Sino Biological, Inc. Introduction and Business Overview
Table 109. Sino Biological, Inc. PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sino Biological, Inc. PSMA Antibody Product
Table 111. Sino Biological, Inc. Recent Development
Table 112. ACROBiosystems Company Information
Table 113. ACROBiosystems Introduction and Business Overview
Table 114. ACROBiosystems PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. ACROBiosystems PSMA Antibody Product
Table 116. ACROBiosystems Recent Development
Table 117. Bio-Techne Company Information
Table 118. Bio-Techne Introduction and Business Overview
Table 119. Bio-Techne PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Bio-Techne PSMA Antibody Product
Table 121. Bio-Techne Recent Development
Table 122. Abcam Company Information
Table 123. Abcam Introduction and Business Overview
Table 124. Abcam PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Abcam PSMA Antibody Product
Table 126. Abcam Recent Development
Table 127. Elabscience Biotechnology Inc. Company Information
Table 128. Elabscience Biotechnology Inc. Introduction and Business Overview
Table 129. Elabscience Biotechnology Inc. PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Elabscience Biotechnology Inc. PSMA Antibody Product
Table 131. Elabscience Biotechnology Inc. Recent Development
Table 132. LifeSpan BioSciences, Inc Company Information
Table 133. LifeSpan BioSciences, Inc Introduction and Business Overview
Table 134. LifeSpan BioSciences, Inc PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. LifeSpan BioSciences, Inc PSMA Antibody Product
Table 136. LifeSpan BioSciences, Inc Recent Development
Table 137. ProSci Incorporated Company Information
Table 138. ProSci Incorporated Introduction and Business Overview
Table 139. ProSci Incorporated PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. ProSci Incorporated PSMA Antibody Product
Table 141. ProSci Incorporated Recent Development
Table 142. Boster Biological Technology Company Information
Table 143. Boster Biological Technology Introduction and Business Overview
Table 144. Boster Biological Technology PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Boster Biological Technology PSMA Antibody Product
Table 146. Boster Biological Technology Recent Development
Table 147. Abbexa Company Information
Table 148. Abbexa Introduction and Business Overview
Table 149. Abbexa PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Abbexa PSMA Antibody Product
Table 151. Abbexa Recent Development
Table 152. Assay Genie Company Information
Table 153. Assay Genie Introduction and Business Overview
Table 154. Assay Genie PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Assay Genie PSMA Antibody Product
Table 156. Assay Genie Recent Development
Table 157. Innovative Research Company Information
Table 158. Innovative Research Introduction and Business Overview
Table 159. Innovative Research PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Innovative Research PSMA Antibody Product
Table 161. Innovative Research Recent Development
Table 162. G&P Biosciences Company Information
Table 163. G&P Biosciences Introduction and Business Overview
Table 164. G&P Biosciences PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. G&P Biosciences PSMA Antibody Product
Table 166. G&P Biosciences Recent Development
Table 167. Arigo Biolaboratories Corp. Company Information
Table 168. Arigo Biolaboratories Corp. Introduction and Business Overview
Table 169. Arigo Biolaboratories Corp. PSMA Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Arigo Biolaboratories Corp. PSMA Antibody Product
Table 171. Arigo Biolaboratories Corp. Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. PSMA Antibody Market Trends
Table 175. PSMA Antibody Market Drivers
Table 176. PSMA Antibody Market Challenges
Table 177. PSMA Antibody Market Restraints
Table 178. PSMA Antibody Distributors List
Table 179. PSMA Antibody Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. PSMA Antibody Product Picture
Figure 2. Global PSMA Antibody Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global PSMA Antibody Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global PSMA Antibody Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Monoclonal Antibody
Figure 6. Global Monoclonal Antibody Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Polyclonal Antibody
Figure 8. Global Polyclonal Antibody Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global PSMA Antibody Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global PSMA Antibody Sales Market Share by Type in 2022 & 2029
Figure 11. North America PSMA Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America PSMA Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe PSMA Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe PSMA Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific PSMA Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific PSMA Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America PSMA Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America PSMA Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa PSMA Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa PSMA Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by PSMA Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by PSMA Antibody Revenue in 2022
Figure 23. PSMA Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Flow Cytometry
Figure 25. Global Flow Cytometry Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of ELISA
Figure 27. Global ELISA Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Western Blot
Figure 29. Global Western Blot Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Immunoprecipitation
Figure 31. Global Immunoprecipitation Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Immunofluorescence
Figure 33. Global Immunofluorescence Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global PSMA Antibody Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global PSMA Antibody Sales Market Share by Application in 2022 & 2029
Figure 38. North America PSMA Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America PSMA Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe PSMA Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe PSMA Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific PSMA Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific PSMA Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America PSMA Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America PSMA Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa PSMA Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. PSMA Antibody Manufacturing Cost Structure
Figure 49. PSMA Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed